Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1000

1.

Transcription-induced formation of extrachromosomal DNA during yeast ageing.

Hull RM, King M, Pizza G, Krueger F, Vergara X, Houseley J.

PLoS Biol. 2019 Dec 3;17(12):e3000471. doi: 10.1371/journal.pbio.3000471. eCollection 2019 Dec.

2.

Loss of perlecan heparan sulfate glycosaminoglycans lowers body weight and decreases islet amyloid deposition in human islet amyloid polypeptide transgenic mice.

Templin AT, Mellati M, Soininen R, Hogan MF, Esser N, Castillo JJ, Zraika S, Kahn SE, Hull RL.

Protein Eng Des Sel. 2019 Nov 26. pii: gzz041. doi: 10.1093/protein/gzz041. [Epub ahead of print]

PMID:
31769491
3.

Adoption of the Coronary Artery Disease-reporting and Data System: Reduced Downstream Testing and Cardiology Referral Rates in Patients with Non-obstructive Coronary Artery Disease.

Boster J, Hull R, Williams MU, Berger J, Sharp A, Fentanes E, Maroules C, Cury R, Thomas D.

Cureus. 2019 Sep 20;11(9):e5708. doi: 10.7759/cureus.5708.

4.

The Impact of Hypoxia on the Host-Pathogen Interaction between Neutrophils and Staphylococcus aureus.

Hajdamowicz NH, Hull RC, Foster SJ, Condliffe AM.

Int J Mol Sci. 2019 Nov 7;20(22). pii: E5561. doi: 10.3390/ijms20225561. Review.

5.

Regulation of alternative splicing in obesity-induced hypertension.

Dlamini Z, Hull R, Makhafola TJ, Mbele M.

Diabetes Metab Syndr Obes. 2019 Aug 28;12:1597-1615. doi: 10.2147/DMSO.S188680. eCollection 2019.

6.

Addressing identity-related barriers to collaboration for conservation through self-affirmation theory and moral foundations theory.

Hurst K, Stern MJ, Hull RB, Axsom D.

Conserv Biol. 2019 Oct 29. doi: 10.1111/cobi.13428. [Epub ahead of print]

PMID:
31663167
7.

Estimation of Acutely Ill Medical Patients at Venous Thromboembolism Risk Eligible for Extended Thromboprophylaxis Using APEX Criteria in US Hospitals.

Martin AC, Huang W, Goldhaber SZ, Hull RD, Hernandez AF, Gibson CM, Anderson FA, Cohen AT.

Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029619880008. doi: 10.1177/1076029619880008.

PMID:
31588785
8.

Extended prophylaxis of venous thromboembolism with betrixaban in acutely ill medical patients with and without cancer: insights from the APEX trial.

Ageno W, Lopes RD, Yee MK, Hernandez A, Hull R, Goldhaber SZ, Gibson CM, Cohen AT.

J Thromb Thrombolysis. 2019 Sep 6. doi: 10.1007/s11239-019-01943-5. [Epub ahead of print]

PMID:
31493287
9.

Net-clinical benefit of extended prophylaxis of venous thromboembolism with betrixaban in medically ill patients aged 80 or more.

Ageno W, Lopes RD, Yee MK, Hernandez A, Hull RD, Goldhaber SZ, Gibson CM, Cohen AT.

J Thromb Haemost. 2019 Dec;17(12):2089-2098. doi: 10.1111/jth.14600. Epub 2019 Aug 26.

PMID:
31392827
10.

Alterations in Life-History Associated With Non-target-site Herbicide Resistance in Alopecurus myosuroides.

Comont D, Knight C, Crook L, Hull R, Beffa R, Neve P.

Front Plant Sci. 2019 Jun 26;10:837. doi: 10.3389/fpls.2019.00837. eCollection 2019.

11.

Expression Analysis of RbBP6 in human cancers: a Prospective biomarker.

Mbita Z, Hull R, Mbele M, Makhafola T, Dlamini Z.

Anticancer Drugs. 2019 Sep;30(8):767-773. doi: 10.1097/CAD.0000000000000809.

PMID:
31274515
12.

Treating Multidimensional Presenting Problems with a Mutually Integrative Approach Using the Genogram.

Browning S, Hull R.

Fam Process. 2019 Sep;58(3):656-668. doi: 10.1111/famp.12470. Epub 2019 Jun 29.

PMID:
31254467
13.

Characterization of Major and Clinically Relevant Non-Major Bleeds in the APEX Trial.

Yee MK, Gibson CM, Nafee T, Kerneis M, Daaboul Y, Korjian S, Chi G, AlKhalfan F, Hernandez AF, Hull RD, Cohen AT, Goldhaber SZ.

TH Open. 2019 Apr 17;3(2):e103-e108. doi: 10.1055/s-0039-1685496. eCollection 2019 Apr.

14.

Vaccine: friend or foe? Double seropositive vasculitis following influenza vaccination.

Norton B, Kon SP, Perera R, Hull R.

Oxf Med Case Reports. 2019 May 31;2019(5):omz031. doi: 10.1093/omcr/omz031. eCollection 2019 May.

15.

Esophageal cancer genetics in South Africa.

Alaouna M, Hull R, Penny C, Dlamini Z.

Clin Exp Gastroenterol. 2019 Apr 23;12:157-177. doi: 10.2147/CEG.S182000. eCollection 2019. Review.

16.

Evaluation of unmet clinical needs in prophylaxis and treatment of venous thromboembolism in high-risk patient groups: cancer and critically ill.

Brenner B, Hull R, Arya R, Beyer-Westendorf J, Douketis J, Elalamy I, Imberti D, Zhai Z.

Thromb J. 2019 Apr 15;17:6. doi: 10.1186/s12959-019-0196-6. eCollection 2019. Review.

17.

RBBP6 Is Abundantly Expressed in Human Cervical Carcinoma and May Be Implicated in Its Malignant Progression.

Dlamini Z, Ledwaba T, Hull R, Naicker S, Mbita Z.

Biomark Cancer. 2019 Mar 11;11:1179299X19829149. doi: 10.1177/1179299X19829149. eCollection 2019.

18.

Evolutionary epidemiology predicts the emergence of glyphosate resistance in a major agricultural weed.

Comont D, Hicks H, Crook L, Hull R, Cocciantelli E, Hadfield J, Childs D, Freckleton R, Neve P.

New Phytol. 2019 Aug;223(3):1584-1594. doi: 10.1111/nph.15800. Epub 2019 Apr 11.

PMID:
30883786
19.

Reduction of Cardiovascular Mortality and Ischemic Events in Acute Medically Ill Patients.

Nafee T, Gibson CM, Yee MK, Kerneis M, Daaboul Y, Korjian S, Chi G, Kalayci A, Afzal MK, Kazmi H, Datta S, AlKhalfan F, Hernandez AF, Hull RD, Harrington RA, Cohen AT, Goldhaber SZ.

Circulation. 2019 Feb 26;139(9):1234-1236. doi: 10.1161/CIRCULATIONAHA.118.038654. No abstract available.

PMID:
30802169
20.

Extended-duration betrixaban versus shorter-duration enoxaparin for venous thromboembolism prophylaxis in critically ill medical patients: an APEX trial substudy.

Chi G, Gibson CM, Kalayci A, Cohen AT, Hernandez AF, Hull RD, Kahe F, Jafarizade M, Sharfaei S, Liu Y, Harrington RA, Goldhaber SZ.

Intensive Care Med. 2019 Apr;45(4):477-487. doi: 10.1007/s00134-019-05565-6. Epub 2019 Feb 18.

PMID:
30778649
21.

Survival in a bad neighborhood: pancreatic islets in cystic fibrosis.

Norris AW, Ode KL, Merjaneh L, Sanda S, Yi Y, Sun X, Engelhardt JF, Hull RL.

J Endocrinol. 2019 Feb 1. pii: JOE-18-0468.R1. doi: 10.1530/JOE-18-0468. [Epub ahead of print] Review.

PMID:
30759072
22.

Probing the Meaning of Persistent Propeptide Release in Type 1 Diabetes.

Kahn SE, Templin AT, Hull RL, Verchere CB.

Diabetes Care. 2019 Feb;42(2):183-185. doi: 10.2337/dci18-0054. No abstract available.

PMID:
30665962
23.

Cardiac Tamponade from Purulent Pericarditis due to Cutibacterium acnes.

Farhat-Sabet A, Hull R, Thomas D.

Case Rep Cardiol. 2018 Nov 18;2018:4739830. doi: 10.1155/2018/4739830. eCollection 2018.

24.

Asymptomatic Deep Vein Thrombosis is Associated with an Increased Risk of Death: Insights from the APEX Trial.

Kalayci A, Gibson CM, Chi G, Yee MK, Korjian S, Datta S, Nafee T, Gurin M, Haroian N, Qamar I, Hull RD, Hernandez AF, Cohen AT, Harrington RA, Goldhaber SZ.

Thromb Haemost. 2018 Dec;118(12):2046-2052. doi: 10.1055/s-0038-1675606. Epub 2018 Nov 12.

PMID:
30419597
25.

Stochasticity in materials structure, properties, and processing-A review.

Hull R, Keblinski P, Lewis D, Maniatty A, Meunier V, Oberai AA, Picu CR, Samuel J, Shephard MS, Tomozawa M, Vashishth D, Zhang S.

Appl Phys Rev. 2018 Mar;5(1). pii: 011302. doi: 10.1063/1.4998144. Epub 2018 Mar 7.

26.

Inverse relationship of serum albumin to the risk of venous thromboembolism among acutely ill hospitalized patients: Analysis from the APEX trial.

Chi G, Gibson CM, Liu Y, Hernandez AF, Hull RD, Cohen AT, Harrington RA, Goldhaber SZ.

Am J Hematol. 2019 Jan;94(1):21-28. doi: 10.1002/ajh.25296. Epub 2018 Oct 17.

PMID:
30252149
27.

Farewell Stan Stanley Falkow: 1934-2018.

Cabello FC, Cohen SN, Curtiss R 3rd, Dougan G, van Embden J, Finlay BB, Heffron F, Helinski D, Hull R, Hull S, Isberg R, Kopecko DJ, Levy S, Mekalanos J, Ortiz JM, Rappuoli R, Roberts MC, So M, Timmis KN.

Environ Microbiol. 2018 Jul;20(7):2322-2333. doi: 10.1111/1462-2920.14308. Epub 2018 Aug 26. No abstract available.

PMID:
30146753
28.

Use of the PET ligand florbetapir for in vivo imaging of pancreatic islet amyloid deposits in hIAPP transgenic mice.

Templin AT, Meier DT, Willard JR, Wolden-Hanson T, Conway K, Lin YG, Gillespie PJ, Bokvist KB, Attardo G, Kahn SE, Scheuner D, Hull RL.

Diabetologia. 2018 Oct;61(10):2215-2224. doi: 10.1007/s00125-018-4695-y. Epub 2018 Jul 25.

29.

Translocator Protein (TSPO) as a Potential Biomarker in Human Cancers.

Bhoola NH, Mbita Z, Hull R, Dlamini Z.

Int J Mol Sci. 2018 Jul 25;19(8). pii: E2176. doi: 10.3390/ijms19082176.

30.

Directed Self-Assembly of Ge Quantum Dots Using Focused Si2+ Ion Beam Patterning.

Chee SW, Kammler M, Graham J, Gignac L, Reuter MC, Hull R, Ross FM.

Sci Rep. 2018 Jun 19;8(1):9361. doi: 10.1038/s41598-018-27512-z.

31.

Association of Anemia with Venous Thromboembolism in Acutely Ill Hospitalized Patients: An APEX Trial Substudy.

Chi G, Gibson CM, Hernandez AF, Hull RD, Kazmi SHA, Younes A, Walia SS, Pitliya A, Singh A, Kahe F, Kalayci A, Nafee T, Kerneis M, AlKhalfan F, Cohen AT, Harrington RA, Goldhaber SZ.

Am J Med. 2018 Aug;131(8):972.e1-972.e7. doi: 10.1016/j.amjmed.2018.03.031. Epub 2018 Apr 13.

PMID:
29660351
32.

Symptomatic event reduction with extended-duration betrixaban in acute medically ill hospitalized patients.

Gibson CM, Nafee T, Yee MK, Chi G, Korjian S, Daaboul Y, AlKhalfan F, Kerneis M, Goldhaber SZ, Hull R, Hernandez AF, Cohen AT, Harrington RA.

Am Heart J. 2018 Apr;198:84-90. doi: 10.1016/j.ahj.2017.12.015. Epub 2017 Dec 27.

PMID:
29653652
33.

Ortervirales: New Virus Order Unifying Five Families of Reverse-Transcribing Viruses.

Krupovic M, Blomberg J, Coffin JM, Dasgupta I, Fan H, Geering AD, Gifford R, Harrach B, Hull R, Johnson W, Kreuze JF, Lindemann D, Llorens C, Lockhart B, Mayer J, Muller E, Olszewski NE, Pappu HR, Pooggin MM, Richert-Pöggeler KR, Sabanadzovic S, Sanfaçon H, Schoelz JE, Seal S, Stavolone L, Stoye JP, Teycheney PY, Tristem M, Koonin EV, Kuhn JH.

J Virol. 2018 May 29;92(12). pii: e00515-18. doi: 10.1128/JVI.00515-18. Print 2018 Jun 15. No abstract available.

34.

Changes in the proteome of the problem weed blackgrass correlating with multiple-herbicide resistance.

Tétard-Jones C, Sabbadin F, Moss S, Hull R, Neve P, Edwards R.

Plant J. 2018 May;94(4):709-720. doi: 10.1111/tpj.13892. Epub 2018 Apr 25.

35.

Neprilysin Deficiency Is Associated With Expansion of Islet β-Cell Mass in High Fat-Fed Mice.

Parilla JH, Hull RL, Zraika S.

J Histochem Cytochem. 2018 Jul;66(7):523-530. doi: 10.1369/0022155418765164. Epub 2018 Mar 19.

36.

Islet Interleukin-1β Immunoreactivity Is an Early Feature of Cystic Fibrosis That May Contribute to β-Cell Failure.

Hull RL, Gibson RL, McNamara S, Deutsch GH, Fligner CL, Frevert CW, Ramsey BW, Sanda S.

Diabetes Care. 2018 Apr;41(4):823-830. doi: 10.2337/dc17-1387. Epub 2018 Feb 1.

37.

The factors driving evolved herbicide resistance at a national scale.

Hicks HL, Comont D, Coutts SR, Crook L, Hull R, Norris K, Neve P, Childs DZ, Freckleton RP.

Nat Ecol Evol. 2018 Mar;2(3):529-536. doi: 10.1038/s41559-018-0470-1. Epub 2018 Feb 12.

PMID:
29434350
38.

Association of D-dimer Levels with Clinical Event Rates and the Efficacy of Betrixaban versus Enoxaparin in the APEX Trial.

Gibson CM, Jennings LK, Chi G, Yee MK, Halaby R, Nafee T, AlKhalfan F, Kerneis M, Korjian S, Daaboul Y, Goldhaber SZ, Hull RD, Hernandez AF, Cohen AT, Harrington RA.

TH Open. 2018 Jan 8;2(1):e16-e24. doi: 10.1055/s-0037-1615288. eCollection 2018 Jan.

39.

Extended-Duration Betrixaban Reduces the Risk of Rehospitalization Associated With Venous Thromboembolism Among Acutely Ill Hospitalized Medical Patients: Findings From the APEX Trial (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban Trial).

Chi G, Yee MK, Amin AN, Goldhaber SZ, Hernandez AF, Hull RD, Cohen AT, Harrington RA, Gibson CM.

Circulation. 2018 Jan 2;137(1):91-94. doi: 10.1161/CIRCULATIONAHA.117.031187. No abstract available.

PMID:
29279341
40.

Thrombus Burden of Deep Vein Thrombosis and Its Association with Thromboprophylaxis and D-Dimer Measurement: Insights from the APEX Trial.

Chi G, Goldhaber SZ, Hull RD, Hernandez AF, Kerneis M, Al Khalfan F, Cohen AT, Harrington RA, Gibson CM.

Thromb Haemost. 2017 Dec;117(12):2389-2395. doi: 10.1160/TH17-08-0538. Epub 2017 Dec 6.

PMID:
29212126
41.

Increased benefit of betrixaban among patients with a history of venous thromboembolism: a post-hoc analysis of the APEX trial.

Yee MK, Nafee T, Daaboul Y, Korjian S, AlKhalfan F, Kerneis M, Wiest C, Goldhaber SZ, Hernandez AF, Hull RD, Cohen AT, Harrington RA, Gibson CM.

J Thromb Thrombolysis. 2018 Jan;45(1):1-8. doi: 10.1007/s11239-017-1583-0.

PMID:
29188425
42.

The implications of spatially variable pre-emergence herbicide efficacy for weed management.

Metcalfe H, Milne AE, Hull R, Murdoch AJ, Storkey J.

Pest Manag Sci. 2018 Mar;74(3):755-765. doi: 10.1002/ps.4784. Epub 2017 Dec 14.

43.

Coating of silicone with mannoside-PAMAM dendrimers to enhance formation of non-pathogenic Escherichia coli biofilms against colonization of uropathogens.

Zhu Z, Yu F, Chen H, Wang J, Lopez AI, Chen Q, Li S, Long Y, Darouiche RO, Hull RA, Zhang L, Cai C.

Acta Biomater. 2017 Dec;64:200-210. doi: 10.1016/j.actbio.2017.10.008. Epub 2017 Oct 9.

PMID:
29024820
44.

Measuring the effectiveness of management interventions at regional scales by integrating ecological monitoring and modelling.

Freckleton RP, Hicks HL, Comont D, Crook L, Hull R, Neve P, Childs DZ.

Pest Manag Sci. 2018 Oct;74(10):2287-2295. doi: 10.1002/ps.4759. Epub 2017 Nov 23.

45.

A kinetic Monte Carlo approach to study fluid transport in pore networks.

Apostolopoulou M, Day R, Hull R, Stamatakis M, Striolo A.

J Chem Phys. 2017 Oct 7;147(13):134703. doi: 10.1063/1.4985885.

PMID:
28987117
46.

N-terminal pro-B-type natriuretic peptide and the risk of stroke among patients hospitalized with acute heart failure: an APEX trial substudy.

Chi G, Januzzi JL, Korjian S, Daaboul Y, Goldhaber SZ, Hernandez AF, Hull RD, Gold A, Cohen AT, Harrington RA, Gibson CM.

J Thromb Thrombolysis. 2017 Nov;44(4):457-465. doi: 10.1007/s11239-017-1552-7.

PMID:
28905172
47.

Notes from the Field: Fatal Yellow Fever in a Traveler Returning From Peru - New York, 2016.

Newman AP, Becraft R, Dean AB, Hull R, Backenson B, Hale G, Laven J, Bhatnagar J, Staples JE.

MMWR Morb Mortal Wkly Rep. 2017 Sep 1;66(34):914-915. doi: 10.15585/mmwr.mm6634a5. No abstract available.

48.

Competing risk analysis in a large cardiovascular clinical trial: An APEX substudy.

Arbetter DF, Jain P, Yee MK, Michalak N, Hernandez AF, Hull RD, Goldhaber SZ, Harrington RA, Gold A, Cohen AT, Gibson CM.

Pharm Stat. 2017 Nov;16(6):445-450. doi: 10.1002/pst.1823. Epub 2017 Aug 24.

PMID:
28840662
49.

African medicinal plants and their derivatives: Current efforts towards potential anti-cancer drugs.

Mbele M, Hull R, Dlamini Z.

Exp Mol Pathol. 2017 Oct;103(2):121-134. doi: 10.1016/j.yexmp.2017.08.002. Epub 2017 Aug 8. Review.

PMID:
28797846
50.

Effect of extended-duration thromboprophylaxis on venous thromboembolism and major bleeding among acutely ill hospitalized medical patients: a bivariate analysis.

Chi G, Goldhaber SZ, Kittelson JM, Turpie AGG, Hernandez AF, Hull RD, Gold A, Curnutte JT, Cohen AT, Harrington RA, Gibson CM.

J Thromb Haemost. 2017 Oct;15(10):1913-1922. doi: 10.1111/jth.13783. Epub 2017 Sep 4.

Supplemental Content

Support Center